Given the involvement of TFs in viral infection, neuroinflammation and apoptosis, follow up functional studies will be necessary to verify our findings and explore the mechanistic impacts of these candidate TF-genes’ regulation on the outcome of the FUS- and SOD1-ALS disease and might provide potential clues for the development of new therapeutic strategies. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.